Serplulimab Combined With CCRT for LS-SCLC.

Clinical trial NCT06295926 · RECRUITING

Trial details

NCT number: NCT06295926
Sponsor: Peking Union Medical College Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer

Start date: 2024-04-04
Primary completion: 2027-01-25
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.